Diet-induced obesity promotes a myeloma-like condition in vivo. by Lwin, S, Olechnowicz, S, Fowler, J, Edwards, C

Tumor-host cell interactions in the bone disease of myeloma. by Fowler, J, Edwards, C, Croucher, P

Decreased bone marrow-derived adiponectin contributes to myeloma pathogenesis in vivo by Fowler, J, Mundy, G, Lwin, S, Edwards, C

Host Bone Marrow-Derived Stromal Cells Promote Myeloma Initiation and Development of Osteolysis by Fowler, J, Mundy, G, Lwin, S, Edwards, C

Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1. by Fowler, J, Mundy, G, Lwin, S, Edwards, C

Increasing adiponectin via an apolipoprotein peptide mimetic, L-4F, increases bone formation in normal mice and prevents myeloma bone disease in vivo by Fowler, J, Lwin, S, Mundy, G, Edwards, C

Production planning and control for semiconductor wafer fabrication facilities : modeling, analysis, and systems / by Mn̲ch, Lars, Fowler, J. W., Mason, Scott J.

Organisational culture and post-merger integration in an academic health centre: a mixed-methods study. by Ovseiko, P, Melham, K, Fowler, J, Buchan, A

Host-derived MMP-7 decreases myeloma progression in vivo: An unexpected role for MMP-7 and osteopontin in myeloma pathogenesis by Lwin, S, Lynch, C, Fowler, J, Mundy, G, Edwards, C

A murine model of myeloma that allows genetic manipulation of the host microenvironment. by Fowler, J, Mundy, G, Lwin, S, Lynch, C, Edwards, C

Activation of Nrf2-regulated glutathione pathway genes by ischemic preconditioning. by Bell, K, Fowler, J, Al-Mubarak, B, Horsburgh, K, Hardingham, G

A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo by Lwin, S, Fowler, J, Drake, M, Edwards, J, Lynch, C, Edwards, C

Community structure in Congressional cosponsorship networks by Zhang, Y, Friend, A, Traud, A, Porter, M, Fowler, J, Mucha, P

Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease. by Fowler, J, Lwin, S, Drake, M, Edwards, J, Kyle, R, Mundy, G, Edwards, C

Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo. by Edwards, C, Lwin, S, Fowler, J, Oyajobi, B, Zhuang, J, Bates, A, Mundy, G

Blocking TGF beta Signaling Reduces Gammopathy and Improves Bone Volume and Strength In Vivo by Hart, A, Fowler, J, Lwin, S, Munoz, SA, O'Quinn, E, Nyman, J, Edwards, C, Mundy, G

Protein profiling in myeloma in vivo; Effects of bortezomib in a mouse model of myeloma by Edwards, C, Caldwell, R, Bates, A, Fowler, J, Edwards, JR, Oyajobi, B, Lwin, S, Zhang, J, Mundy, G

The ubiquitin-proteasome pathway is dysregulated in myeloma cells in the bone microenvironment in vivo by Edwards, C, Fowler, J, Caldwell, R, Bates, A, Edwards, JR, Zhang, J, Foehr, D, Parker, R, Roberts, A, Mundy, G

The subtype of GluN2 C-terminal domain determines the response to excitotoxic insults. by Martel, M, Ryan, T, Bell, K, Fowler, J, McMahon, A, Al-Mubarak, B, Komiyama, N, Horsburgh, K, Kind, P, Grant, S, Wyllie, D, Hardingham, G

Disentangling the Planet from the Star in Late-Type M Dwarfs: A Case Study of TRAPPIST-1g by Wakeford, HR, Lewis, NK, Fowler, J, Bruno, G, Wilson, TJ, Moran, SE, Valenti, J, Batalha, NE, Filippazzo, J, Bourrier, V, Hörst, SM, Lederer, SM, de Wit, J

Get full text